His scientific interests lie mostly in Internal medicine, Transplantation, Surgery, Kidney transplantation and Kidney disease. His work carried out in the field of Internal medicine brings together such families of science as Placebo, Endocrinology and Cardiology. His biological study spans a wide range of topics, including Risk factor and Hemodialysis.
The various areas that Alan G. Jardine examines in his Transplantation study include Diabetes mellitus, Immunosuppression, Fluvastatin, Intensive care medicine and Kidney. His Surgery research includes themes of Gastroenterology and Renal function. His Kidney transplantation research is multidisciplinary, incorporating perspectives in Creatinine and Urinary system.
His main research concerns Internal medicine, Transplantation, Cardiology, Surgery and Intensive care medicine. Internal medicine and Endocrinology are commonly linked in his work. His Transplantation research focuses on Risk factor and how it connects with Vascular disease.
His research investigates the connection between Cardiology and topics such as Left ventricular hypertrophy that intersect with issues in Cardiomyopathy. His work deals with themes such as Creatinine and Fluvastatin, which intersect with Surgery. The study incorporates disciplines such as Nephrology, Urology, Nephropathy, Renal replacement therapy and Proteinuria in addition to Kidney disease.
Alan G. Jardine mainly focuses on Internal medicine, Cardiology, Kidney disease, Transplantation and Hemodialysis. In his study, Phosphate is inextricably linked to Endocrinology, which falls within the broad field of Internal medicine. His work on Troponin as part of general Cardiology research is often related to Index, thus linking different fields of science.
His Kidney disease research includes elements of Diabetes mellitus, Placebo, Nephrology and Renal function. His research integrates issues of Gastroenterology and Randomized controlled trial in his study of Placebo. His work carried out in the field of Hemodialysis brings together such families of science as Allopurinol, QT interval, Arteriovenous fistula and Myocardial fibrosis.
Internal medicine, Kidney disease, Intensive care medicine, Transplantation and Renal function are his primary areas of study. His Internal medicine study incorporates themes from Gastroenterology, Endocrinology and Cardiology. His studies deal with areas such as Epidemiology and Risk factor as well as Kidney disease.
His Intensive care medicine research incorporates themes from Coronary artery disease, Disease and Psychological intervention. His Renal function research incorporates elements of Nephrology, Surgery and Proteinuria. His work on Tacrolimus as part of his general Surgery study is frequently connected to Text mining, thereby bridging the divide between different branches of science.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial
Murray D. Esler;Henry Krum;Henry Krum;Paul A. Sobotka;Markus P. Schlaich.
The Lancet (2010)
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
Bengt C. Fellström;Alan G. Jardine;Roland E. Schmieder;Hallvard Holdaas.
The New England Journal of Medicine (2009)
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial
Hallvard Holdaas;Bengt Fellstrom;Alan G Jardine;Ingar Holme.
The Lancet (2003)
The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients
Atul Humar;Yvon Lebranchu;Flavio Vincenti;Emily A.Emily Blumberg.
American Journal of Transplantation (2010)
Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients
A Asberg;A Humar;H Rollag;A G Jardine.
American Journal of Transplantation (2007)
Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort.
Tara Anne Collidge;Peter Campbell Thomson;Patrick Barry Mark;James Phillip Traynor.
Radiology (2007)
Guidelines for the treatment and management of new-onset diabetes after transplantation
Alan Wilkinson;Jaime Davidson;Francesco Dotta;Philip D Home.
Clinical Transplantation (2005)
Long term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study
H. Holdaas;B. Fellström;E. Cole;G. Nyberg.
American Journal of Transplantation (2005)
Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy
P.N Harden;P.A Rowe;R.S.C Rodger;B.J.R Junor.
The Lancet (1995)
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
Jane Armitage;Colin Baigent;Elizabeth Barnes;D John Betteridge.
The Lancet (2019)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Oslo University Hospital
Norwegian School of Sport Sciences
University of Dundee
University of Lorraine
University of Erlangen-Nuremberg
University of Glasgow
Heidelberg University
Linköping University
Oslo University Hospital
Baylor College of Medicine
Stanford University
Universidade de São Paulo
University of Padua
Norwegian University of Science and Technology
University of Akron
Helmholtz Centre for Environmental Research
Macquarie University
Heinrich Heine University Düsseldorf
INRAE : Institut national de recherche pour l'agriculture, l'alimentation et l'environnement
Chinese Academy of Sciences
Grenoble Alpes University
University of Melbourne
University of Paris-Saclay
Charité - University Medicine Berlin
Columbia University
University of Kentucky